Davis Drug Discover Group is categorized under Commercial Biotechnical Research in Davis, CA and active since 2011.
Davis Drug Discover Group was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Arthur Wellman at the company’s single location by writing to 220 Inca Place, Davis, California CA 95616 or by phoning (916) 273-4414. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Davis Drug Discover Group |
| Contact Person: | Arthur Wellman |
| Address: | 220 Inca Place, Davis, California 95616 |
| Phone Number: | (916) 273-4414 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Davis Drug Discover Group was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Arthur Wellman for inquiries that concern Davis Drug Discover Group by calling the company number (916) 273-4414, as your correspondence is most welcome. Additionally, the physical location of the single location of Davis Drug Discover Group can be found at the coordinates 38.569218,-121.750658 as well as the street address 220 Inca Place in Davis, California 95616.
For its online presence, you may visit Davis Drug Discover Group’s website at and engage with its social media outlets through on Twitter and on Facebook.